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Introduction: Methamphetamine is a highly potent, addictive drug that is widely 
abused in many countries around the world. Methamphetamine produces a general 
state of well-being along with increased wakefulness, talkativeness, and physical 
activity and decreased appetite. Behavioral treatment programs have had some 
success in the treatment of methamphetamine addiction, yet many patients continue 
to relapse after repeatedly seeking treatment. Thus, pharmacotherapies treatments for 
methamphetamine addiction are being evaluated.  
Bupropion is an atypical antidepressant with stimulant properties. This drug has 
been used off-label to treat methamphetamine addicts, thus prompting the need for 
systematic investigations of its efficacy. 
Methods and Results: Male wistar rats, weighing 200–250 g (8 weeks old) at the 
start of the experiment. In the self-administration study, rats were surgically 
prepared with indwelling jugular catheters. After the surgery rats were trained to 
press a lever of methamphetamine reinforcement (0.05 mg/kg/injection) in operant 
boxes under baseline conditions. When responding stabilized, rats entered the acute 
testing phase. Each rat was tested with a unique order of vehicle, 10, 30, and 60 
mg/kg bupropion. Each solution was administered IP 5 min before placement in the 
chamber for a regular self-administration session and each test was separated by at 
least 2 maintenance days of methamphetamine self-administration without drug 
pretreatment. Bupropion pretreatment appeared to decrease active lever responding. 
Consistent with the active lever data, rats treated with 60 mg/kg bupropion took 
significantly fewer total methamphetamine infusions in comparison to the other 2 
groups. When Control rats (n=6) (i.e., those pretreated with saline in the previous 
phase) were given an acute injection of 30 mg/kg bupropion, lever pressing 
decreased. 
Conclusions: Several questions remain about bupropion’s impact during 
withdrawal, abstinence, and relapse in a preclinical setting. Research investigating 
these aspects of addiction will help provide a clearer picture on the effects of 
bupropion on methamphetamine self-administration in laboratory animals and 
methamphetamine abuse in humans. 
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